Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Large-scale randomized clinical prevention and treatment study of metabolic syndrome
ChiCTR-TRC-08000295Phase 4Completed
- Sponsor
- Fuwai Hospital
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of telmisartan and pioglitazone in cardiometabolic risk (CMR) (2 arms), sponsored by Fuwai Hospital. Primary endpoints: Change in waist circumference, Change in body weight and 7 more. Started Dec 2006; status: completed.
02
Drugs
telmisartanpioglitazone
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on ChiCTR-TRC-08000295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000295.